Species specificity of the fibrinolytic effects of activated protein C

• Published in: Thrombosis research Vol. 63; no. 1; pp. 123 - 131
• Main Authors: Weinstein, Ralph E, Walker, Frederick J
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Ltd 01.07.1991; Elsevier Science
• Subjects: activated Protein C; Animals; Biological and medical sciences; Blood Coagulation - drug effects; Blood coagulation. Blood cells; Blood Proteins - pharmacology; Cattle; Coagulation; Fibrinolysis; Fibrinolysis - drug effects; Fundamental and applied biological sciences. Psychology; General aspects, investigation methods, hemostasis, fibrinolysis; Glycoproteins - pharmacology; Humans; In Vitro Techniques; Molecular and cellular biology; Plasminogen Activator Inhibitor; Plasminogen Inactivators - metabolism; Protein C - pharmacology; Protein S; Rabbits; Species Specificity; Tissue-Plasminogen activator; Plasminogen Activator Inhibitor; Tissue-Plasminogen activator; activated Protein C; Fibrinolysis; Coagulation; Human; Blood coagulation; Enzyme; Enzyme inhibitor; Rabbit; Plasminogen activator; Vitronectin; Activation; Lagomorpha; Biological activity; Blood plasma; Vertebrata; Mammalia; C reactive protein; Comparative study
• ISSN: 0049-3848; 1879-2472
• DOI: 10.1016/0049-3848(91)90275-2

Activated protein C (APC) has been shown to stimulate fibrinolysis in both in vitro and in vivo experimental systems. In order to test the importance of protein S in the fibrinolytic activity of APC we have compared the activity of APC, prepared from rabbit, bovine and human plasma, in the stimulation of whole blood clot lysis, the inactivation of plasminogen activator inhibitors and anticoagulant activity. When whole blood clot lysis was performed using tissue plasminogen activator in either human or rabbit blood, APC was found to enhance clot lysis in a species specific manner that paralleled the pattern observed for its anticoagulant activity. Bovine APC, was the poorest stimulator of fibrinolysis in human plasma. However, if bovine protein S was also added to human plasma, bovine APC was as effective in promoting fibrinolysis as human APC. In contrast, no species specific effects on the inactivation of plasminogen activator inhibitor activity was observed. Though substantial effects of APC on plasminogen activator inhibitor levels were made by rabbit, human and bovine activated protein C in human plasma, there was no effect of activated protein C on the rate of clot lysis of human plasma. These results suggest that protein S is important for the expression of the fibrinolytic activity of activated protein C and that the effect of protein S may be useful for the differentiation of fibrinolytic effects of activated protein C that may be related to the inactivation of plasminogen activator inhibitors and those that are not.